TeklaLife Sciences Investors (HQL) Financials
HQL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 402.6 million | 666959 |
2023-03-31 | 432.7 million | 10.0 million |
2022-12-31 | 432.7 million | 10.0 million |
2022-09-30 | 414.7 million | 16.8 million |
HQL Free Cash Flow and Stock based compensation
No data available :(
HQL Net Income
Date | Net Income |
---|---|
2023-09-30 | -11.5 million |
2023-03-31 | 16.9 million |
2022-12-31 | 16.9 million |
2022-09-30 | -14.2 million |
HQL Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 477 | - | - |
2023-03-31 | 822 | - | - |
2022-12-31 | 822 | - | - |
2022-09-30 | 445 | - | - |
HQL Shares Outstanding
HQL Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | - | - | - |
2023-03-31 | - | - | 1.4 million | - |
2022-12-31 | - | - | 1.4 million | - |
2022-09-30 | - | - | 1.4 million | - |
HQL Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 29.6 million | 2.6 million |
2023-03-31 | 9.8 million | 2.7 million |
2022-12-31 | 964636 | - |
2022-09-30 | 21.7 million | 2.6 million |
HQL
Price: $12.97
Dividend Yield: 0.10%
Forward Dividend Yield: 12.03%
Payout Ratio: 197.47%
Dividend Per Share: 1.56 USD
Earnings Per Share: 0.79 USD
P/E Ratio: 17.54
Exchange: NYQ
Sector: Financial Services
Industry: Asset Management
Volume: 93486
Market Capitalization: 355.0 million
Average Dividend Frequency: 4
Years Paying Dividends: 29
DGR3: -2.82%
DGR5: -4.18%
DGR10: 2.24%
DGR20: 12.02%